Alois Alzheimer
Alois Alzheimer (14 June 1864 – 19 December 1915) was a German psychiatrist, neuropathologist, and anatomist who is best known for identifying and describing the first published case of a specific neurodegenerative disorder, which was subsequently named Alzheimer's disease in his honor.
Early Life and Education
Alois Alzheimer was born on 14 June 1864 in Marktbreit, a town in the Kingdom of Bavaria, to the notary Eduard Román Alzheimer and Anna Therese. His family moved to Aschaffenburg when he was young, where he attended the local Gymnasium. He began his medical studies in 1883 at the Friedrich Wilhelm University in Berlin. During his studies, he spent a semester at the University of Tübingen and later transferred to the Julius-Maximilians-Universität Würzburg, where he graduated with his medical degree in 1887. Following his graduation, he worked as an assistant at the university's psychiatric clinic for five months before taking a position at the state asylum in Frankfurt am Main.
Career and Professional Collaborations
In Frankfurt, Alzheimer worked at the Irrenschloss (Asylum for the Insane), which was directed by Emil Sioli. It was here that he met Franz Nissl, a prominent neuropathologist who introduced him to the microscopic study of brain pathology. Together, Alzheimer and Nissl co-founded the journal Zeitschrift für die gesamte Neurologie und Psychiatrie. In 1895, Alzheimer briefly returned to Tübingen to work with Nissl before moving back to Frankfurt.
His most significant professional collaboration began with Emil Kraepelin, a leading psychiatrist of the time. When Kraepelin moved to the Royal Psychiatric Hospital in Munich in 1903, he invited Alzheimer to join him at the psychiatric clinic of the University of Munich. Alzheimer accepted and became a professor of psychiatry at the university in 1908. Kraepelin's focus on classifying psychiatric disorders and Alzheimer's expertise in brain pathology complemented each other perfectly, leading to significant advancements in the understanding of mental illnesses.
Discovery of Alzheimer's Disease
Alzheimer's most enduring contribution to medicine occurred during his time in Frankfurt. In 1901, he admitted a 51-year-old woman named Auguste Deter to the asylum. She exhibited a rapid and severe decline in cognitive function, characterized by memory loss, language problems, auditory hallucinations, and unpredictable behavior. After her death in 1906, Alzheimer examined her brain using the newly developed Bielschowsky silver staining technique. He observed two distinct pathological features: amyloid plaques (abnormal clusters of protein fragments between nerve cells) and neurofibrillary tangles (twisted strands of protein inside nerve cells).
Alzheimer presented his findings on April 11, 1906, at a meeting of the Southwest German Psychiatrists in Tübingen. Initially, his presentation received little attention. However, he published a detailed paper on the case in 1907, and later reported two similar cases. In 1910, Emil Kraepelin included this specific disease entity in the eighth edition of his influential textbook Psychiatrie, naming it "Alzheimer's disease" (Alzheimersche Krankheit). Kraepelin distinguished it from senile dementia, which was considered a normal part of aging at the time, although modern medicine now recognizes that the pathology of Alzheimer's disease is largely the same as that of senile dementia.
Later Life and Death
In his later years, Alzheimer's health began to deteriorate. He suffered from severe rheumatic fever, which led to complications including endocarditis and heart failure. He also experienced kidney failure and a persistent sore throat. Due to his declining health, he was unable to continue his rigorous research and clinical duties. Alois Alzheimer died on 19 December 1915 in Breslau (now Wrocław, Poland), at the age of 51, while traveling to a sanatorium. He was buried in the Frankfurt Main Cemetery.
Legacy and Honors
Alois Alzheimer's legacy is inextricably linked to the disease that bears his name. His meticulous clinical observations and pioneering use of neuropathological techniques laid the foundation for modern neuroscience and the study of neurodegenerative diseases. Today, Alzheimer's disease is recognized as the most common cause of dementia worldwide, affecting millions of people.
Throughout his life and posthumously, Alzheimer received numerous honors. He was a member of several prestigious scientific societies, including the Society of German Natural Scientists and Physicians. In his hometown of Marktbreit, a museum dedicated to his life and work, the Alois Alzheimer Museum, was established. Furthermore, his name is commemorated in various medical institutions, research centers, and streets across Germany and internationally, ensuring his continued recognition as a foundational figure in psychiatry and neurology.
你感兴趣的百科
日本
日本(Japan),正式国名为日本国,是位于东亚的岛国,地处西太平洋,隔日本海与亚洲大陆东部相望。日本由本州、北海道、九州、四国四个大岛及数千个小岛组成,全国共计14,125个岛屿,构成一个庞大的列岛国家。日本人口约1.23亿,是世界上人口...
国际象棋
国际象棋(Chess)是一种在8×8方格、共64格的棋盘上由两名棋手对弈的策略性棋类游戏,双方各统领十六枚棋子,以将死对方的王为最终目标。国际象棋被广泛视为世界上历史最悠久、智力要求最高的棋艺活动之一,兼具艺术、科学与竞技体育的特质,在全球...
亚洲
Asia(亚洲)是地球上面积最大、人口最多的洲,位于东半球的东北部,北临北冰洋,东濒太平洋,南接印度洋,西以乌拉尔山脉、乌拉尔河、里海、高加索山脉、黑海及土耳其海峡与欧洲为界,西南以苏伊士运河、红海与非洲相邻,东北隔白令海峡与北美洲相望。亚...
DeepSeek(深度求索)
DeepSeek(深度求索),全称杭州深度求索人工智能基础技术研究有限公司,是一家总部位于中国杭州的人工智能研究公司,专注于大型语言模型及相关人工智能技术的研发,公司名称“深度求索”意即“深度探索”。该公司由企业家梁文锋于2023年创立,资...
评论区 (0)
还没有评论,来抢沙发!